Catherine E. Fitzgerald

748 total citations
15 papers, 622 citations indexed

About

Catherine E. Fitzgerald is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Catherine E. Fitzgerald has authored 15 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Cell Biology. Recurrent topics in Catherine E. Fitzgerald's work include Melanoma and MAPK Pathways (8 papers), Synthesis and biological activity (6 papers) and Computational Drug Discovery Methods (3 papers). Catherine E. Fitzgerald is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Synthesis and biological activity (6 papers) and Computational Drug Discovery Methods (3 papers). Catherine E. Fitzgerald collaborates with scholars based in United States. Catherine E. Fitzgerald's co-authors include Stephen J. O’Keefe, Dennis M. Zaller, Keith A. Hruska, Ulises Alvarez, Meenakshi A. Chellaiah, Sangita B. Patel, Giovanna Scapin, V.B. Pikounis, S. Natarajan and Joseph W. Becker and has published in prestigious journals such as Journal of Biological Chemistry, Endocrinology and Nature Structural & Molecular Biology.

In The Last Decade

Catherine E. Fitzgerald

15 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Fitzgerald United States 12 387 264 105 91 76 15 622
Christine Lambert‐van der Brempt United Kingdom 11 520 1.3× 331 1.3× 61 0.6× 243 2.7× 53 0.7× 20 925
Vincent Bordas United Kingdom 8 511 1.3× 280 1.1× 69 0.7× 125 1.4× 55 0.7× 14 836
Gerard Costello United Kingdom 12 526 1.4× 314 1.2× 41 0.4× 243 2.7× 40 0.5× 16 946
Annie Olivier France 10 262 0.7× 160 0.6× 41 0.4× 153 1.7× 68 0.9× 12 492
Melanie Wong United States 17 418 1.1× 160 0.6× 60 0.6× 156 1.7× 43 0.6× 23 830
Rémy Morgentin France 13 292 0.8× 301 1.1× 51 0.5× 173 1.9× 21 0.3× 23 624
Jack A. Kauffman United States 16 416 1.1× 365 1.4× 57 0.5× 81 0.9× 21 0.3× 30 853
Brian Metcalf United States 10 221 0.6× 136 0.5× 34 0.3× 84 0.9× 17 0.2× 18 578
Hadas Reuveni Israel 15 599 1.5× 58 0.2× 34 0.3× 129 1.4× 97 1.3× 27 817
Jag Heer United Kingdom 12 343 0.9× 269 1.0× 54 0.5× 94 1.0× 13 0.2× 21 681

Countries citing papers authored by Catherine E. Fitzgerald

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Fitzgerald more than expected).

Fields of papers citing papers by Catherine E. Fitzgerald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Fitzgerald. The network helps show where Catherine E. Fitzgerald may publish in the future.

Co-authorship network of co-authors of Catherine E. Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Fitzgerald. A scholar is included among the top collaborators of Catherine E. Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Fitzgerald. Catherine E. Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2012). Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2. Bioorganic & Medicinal Chemistry Letters. 22(18). 5979–5983. 14 indexed citations
3.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2010). Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1. Bioorganic & Medicinal Chemistry Letters. 21(1). 411–416. 15 indexed citations
4.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2010). Synthesis and biological activity of 2H-quinolizin-2-one based p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(9). 2765–2769. 11 indexed citations
5.
O’Keefe, Stephen J., John S. Mudgett, Janey N. Parsons, et al.. (2007). Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation. Journal of Biological Chemistry. 282(48). 34663–34671. 70 indexed citations
6.
Natarajan, S., Stephen T. Heller, Kiyean Nam, et al.. (2006). p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design. Bioorganic & Medicinal Chemistry Letters. 16(22). 5809–5813. 19 indexed citations
7.
Boesze‐Battaglia, Kathleen, Frank P. Stefano, Catherine E. Fitzgerald, & Susan Muller‐Weeks. (2006). ROM-1 potentiates photoreceptor specific membrane fusion processes. Experimental Eye Research. 84(1). 22–31. 10 indexed citations
8.
Fitzgerald, Catherine E., Sangita B. Patel, Joseph W. Becker, et al.. (2003). Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. Nature Structural & Molecular Biology. 10(9). 764–769. 153 indexed citations
9.
Liu, Luping, S. Natarajan, Meng‐Hsin Chen, et al.. (2003). SAR of 3,4-Dihydropyrido[3,2-d]pyrimidone p38 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3979–3982. 102 indexed citations
10.
Natarajan, S., David D. Wisnoski, Suresh B. Singh, et al.. (2003). p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold. Bioorganic & Medicinal Chemistry Letters. 13(2). 273–276. 32 indexed citations
11.
Muller‐Weeks, Susan, Kathleen Boesze‐Battaglia, & Catherine E. Fitzgerald. (2002). Deletional Analysis of the Rod Photoreceptor Cell Peripherin/RDS Carboxy-Terminal Region. Experimental Eye Research. 75(2). 143–154. 13 indexed citations
12.
Fitzgerald, Catherine E., et al.. (1999). Carnosine prevents glyceraldehyde 3-phosphate-mediated inhibition of aspartate aminotransferase. Archives of Toxicology. 73(6). 307–309. 24 indexed citations
13.
Fitzgerald, Catherine E., et al.. (1999). Non-Enzymatic Glycosylation (or Glycation) and Inhibition of the Pig Heart Cytosolic Aspartate Aminotransferase by Glyceraldehyde 3-Phosphate. Journal of enzyme inhibition. 15(1). 79–89. 18 indexed citations
14.
Chellaiah, Meenakshi A., Catherine E. Fitzgerald, Ulises Alvarez, & Keith A. Hruska. (1998). c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry. 273(19). 11908–11916. 88 indexed citations
15.
Fitzgerald, Catherine E., et al.. (1996). Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit.. Endocrinology. 137(6). 2432–2440. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026